Intended for healthcare professionals

Rapid response to:

Editor's Choice

Communicable and non-communicable disease

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d5875 (Published 14 September 2011) Cite this as: BMJ 2011;343:d5875

Rapid Response:

Biggest impact 2011: Zinc for free copper toxicosis in Alzheimer

"Evidence2011" asked in an email dated 15 September 2011 signed by
Fiona Godlee, BMJ Group and Carl Heneghan, Centre for Evidence-Based
Medicine, University of Oxford:

What single idea will make the biggest impact on healthcare today?

In response:

Biggest impact will make the idea that type 2 free copper toxicosis
in Alzheimer's disease can best be treated with zinc

Ref 1: - Rapid response: 3 august 2011: Breakthrough: Oral zinc for
free copper toxicosis in Alzheimer's disease.

Ref 2: - Paradigm shift in treatment of Alzheimer's disease: zinc therapy
now a conscientious choice for care of individual patients. International
Journal of Alzheimer's Disease, 2011. in press. Corresponding author:
Dr.T.U.Hoogenraad, Van Galenlaan 20, 3941 VD, Doorn. Email:
tu.hoogenraad@planet.nl.

Competing interests: No competing interests

17 September 2011
Tjaard U. Hoogenraad
retired neurologist
UMC-Utrecht